PROCEPT BioRobotics Corporation

Good morning and welcome to the Procept Biorobotics first quarter 2023 earnings conference call. At this time, all participants are on a listen-only mode. We will be facilitating a question and answer session towards the end of the call today. As a reminder, this call is being recorded for replay purposes. I will now turn the call over to Matt Basco, Vice President of Investment Relations, for a few introductory comments.

Good morning, and thank you for joining ProStep Biorobotics' first quarter 2023 earnings conference call.

Presenting on today's call are Reza Zadno, Chief Executive Officer, and Kevin Waters, Chief Financial Officer. Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. While these forward-looking statements are based on management's current expectations and beliefs, these statements are subject to several risks uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call. These risks and uncertainties are disclosed in more detail in Procept Barobiotics Filings with the Securities Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned to not place undue reliance on these forward-looking statements, which speak only as of today's date, April 27, 2023. Except as required by law, PRSTEP Hour Revised Center takes no obligation to update or revise any forward-looking statements or reflect new information, circumstances, or unanticipated events that may arise. With that, I will now turn the call over to Reza.